Salmeterol tachyphylaxis in steroid treated asthmatic subjects

Thorax

Volumn 51, Issue 11, 1996, Pages 1100-1104

  Booth, H ^b   Bish, R ^a   Walters, J ^a   Whitehead, F ^a   Walters, E H ^a  

^a ALFRED HOSPITAL   (Australia)

^b MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Asthma; Salmetereol; Tachyphylaxis

Indexed keywords

CORTICOSTEROID; METHACHOLINE; PLACEBO; SALMETEROL;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; TACHYPHYLAXIS;

EID: 0029802350     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.11.1100     Document Type: Article

References (22)

1. Lipworth BJ, Struthers AD, McDevitt DG. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. Am Rev Respir Dis 1989;140:586-92.
2. Harvey JE, Tattersfield AE. Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. Thorax 1982;37:280-7.
3. 2 agonists in asthma. N Engl J Med 1992;327:1204-8.
4. Cockcroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993;342:833-7.
5. Johnson M. The preclinical pharmacology of salmeterol: bronchodilator effects. Eur Respir Rev 1991;1:253-6.
6. Newnham DM, McDevitt DG, Lipworth BJ. Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma. Am J Med 1994;97:29-37.
7. Ramage L, Lipworth BJ, Ingram CG, Cree IA, Dhillon DP. Reduced protection against exercise induced broncho-constriction after chronic dosing with salmeterol. Respir Med 1994;88:363-8.
8. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1902;327:1198-203.
9. 2 adrenergic receptor transcription in human lung. Am J Physiol 1995;268:L41-6.
10. Tashkin DP, Connolly ME, Deutsch RI, Hui KK, Littner M, Scarpace P, et al. Subsensitization of β-adrenoreceptors in airways and lymphocytes of healthy and asthmatic subjects. Am Rev Rapir Dis 1982;125:185-93.
11. 2 agonist salmeterol in mild-to-moderate asthmatic patients. Thorax 1993;48: 1121-4.
12. British Thoracic Society. Guidelines for management of asthma in adults: I - Chronic persistent asthma. BMJ 1990;301:651-4.
13. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-24.
14. Woolcock A, Lundback B, Ringdal OLN, et al. Comparison of the effect of addition of salmeterol with doubling the inhaled steroid dose in asthmatic patients. Am J Respir Crit Care Med 1994;149:A280.
15. Grove A, Lipworth BJ. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet 1995;346:210-6.
16. Soler M, Joos L, Bollinger CT, Elsasser S, Perruchard AP. Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine and AMP-induced bronchoconstriction. Eur Respir J 1994; 7:1973-7.
17. Holgate ST, Baldwin CJ, Tattersfield AE. ß-adrenergic agonist resistance in normal human airways. Lancet 1977;ii: 375-7.
18. Roberts JM, Jacobs MM, Cheng JB, Barnes PJ, O'Brien AT, Ballard PJ. Fetal pulmonary beta-adrenergic receptor characterization in the human and in vitro modulation by glucocorticoids in the rabbit. Paediatr Pulnumol 1985;1: S69-76.
19. 2-adrenergic receptor function in airway myocytes. Am J Respir Crit Care Med 1995;151:A582.
20. Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Rapir Cell Mol Biol 1993;8:334-9.
21. Pearlman DS, Chervinsky P, LaForce C, Seltzer JM, Southern DL, Kemp JP, et al. A comparison of satmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992;327:1420-5.
22. Lundback B, Rawlinson DW, Palmer JBD. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. Thorax 1993;48:148-53.